Genome Editing Market To Reach $10.1 Billion By 2026 | Reports And Data
February 27, 2019 07:47 ET
|
Reports And Data
Increasing genomic research across the globe coupled with high incidence of target diseases is expected to stimulate market growth Market Size – USD 3.8 billion in 2018, Market Growth - CAGR of...
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
February 25, 2019 08:00 ET
|
VBI Vaccines, Inc.
Top-line data from Hepatitis B (Sci-B-Vac®) Phase 3 PROTECT trial expected mid-year 2019Encouraging early immunogenicity data from GBM Phase 1/2a supports advancing into Part B of the studyLicense and...
Nash Pharmaceuticals to Present Pre-Clinical Data on Non-Alcoholic Fatty Liver Disease at 2nd Global NASH Congress in London, UK
January 31, 2019 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (the “Company” or “Nash...
eWellness Launches LeadRemedy.com for New Patient Lead Generation
October 31, 2017 09:00 ET
|
eWellness Healthcare Corp
Culver City, CA,, Oct. 31, 2017 (GLOBE NEWSWIRE) -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the state of the art PHZIO Platform for the physical therapy and telehealth...
Healthcare Gamification Market worth over USD 40 Billion by 2024: Global Market Insights, Inc.
October 11, 2017 05:25 ET
|
Global Market Insights, Inc
Ocean View, Delaware, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Healthcare Gamification Market is poised to cross USD 40 billion by 2024; according to a new research report by Global Market Insights, Inc....
Contact Lenses Market will surpass $18bn by 2024
September 18, 2017 06:00 ET
|
Global Market Insights, Inc
Ocean View, Delaware, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Contact Lenses Market is estimated to cross USD 18 billion by 2024; according to a new research report by Global Market Insights, Inc....
Neuronascent Appoints New Board Member
April 12, 2017 06:30 ET
|
Neuronascent, Inc.
CLARKSVILLE, MD--(Marketwired - April 12, 2017) - Neuronascent, Inc., a neuro-pharmaceutical company developing proprietary therapeutics for Alzheimer's disease, Parkinson's disease, and psychiatric...
Purdue-affiliated pharmaceutical company launches product to produce rare disease-fighting compounds
February 15, 2017 08:15 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Feb. 15, 2017 (GLOBE NEWSWIRE) -- A pharmaceutical company based on
Purdue University intellectual property has launched a product line that will allow researchers and medical...
ConverGene Announces a License Agreement With the National Center for Advancing Translational Sciences
December 13, 2016 16:14 ET
|
ConverGene LLC
CAMBRIDGE, Md., Dec. 13, 2016 (GLOBE NEWSWIRE) -- ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the...
Elsevier and the International Society for Neurovascular Disease Partner on Co-branded Neurovascular Disease Book Series
September 29, 2016 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - September 29, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has partnered...